Manuel Jiménez López

Manuel Jiménez López i

Universidad Internacional de La Rioja - La Rioja / Spain
Medical and Health Sciences / Physiology
AD Scientific Index ID: 4650767
International University of La Rioja
person_outline Manuel Jiménez López's MOST POPULAR ARTICLES
1-) Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trialHC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...The Lancet 394 (10193), 121-130, 201916122019
2-) Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trialHC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...The Lancet 394 (10193), 131-138, 20195542019
3-) Timing of surgery following SARS-CoV-2 infection: an international prospective cohort studyCOVIDSurg CollaborativeAnaesthesia 76 (6), 748-758, 2021550*2021
4-) Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsisA Sitges-Serra, MJ Lopez, M Girvent, S Almirall, JJ SanchoJournal of British Surgery 89 (3), 361-367, 20022002002
5-) Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension studyMR McClung, ML O\'Donoghue, SE Papapoulos, H Bone, B Langdahl, ...The lancet Diabetes & endocrinology 7 (12), 899-911, 20191532019